• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Associations of COVID-19 Outcomes with Dialysis Modalities and Settings.COVID-19 结局与透析模式和场所的关联。
Clin J Am Soc Nephrol. 2022 Oct;17(10):1526-1534. doi: 10.2215/CJN.03400322. Epub 2022 Sep 8.
2
Factors Associated With Withdrawal From Maintenance Dialysis: A Case-Control Analysis.与维持性透析退出相关的因素:病例对照分析。
Am J Kidney Dis. 2018 Jun;71(6):831-841. doi: 10.1053/j.ajkd.2017.10.025. Epub 2018 Jan 10.
3
Patient Outcomes After Hospital Discharge to Home With Home Health Care vs to a Skilled Nursing Facility.患者出院后居家接受家庭保健护理与入住专业护理机构的结局比较。
JAMA Intern Med. 2019 May 1;179(5):617-623. doi: 10.1001/jamainternmed.2018.7998.
4
Medicare Skilled Nursing Facility Use and Spending Before and After Introduction of the Public Health Emergency Waiver During the COVID-19 Pandemic.医疗保险熟练护理设施在 COVID-19 大流行期间公共卫生紧急情况豁免引入前后的使用和支出。
JAMA Intern Med. 2023 Jul 1;183(7):637-645. doi: 10.1001/jamainternmed.2023.0770.
5
Risk Factors for Infection-Related Hospitalization in In-Center Hemodialysis.中心血液透析中感染相关住院的危险因素
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2170-80. doi: 10.2215/CJN.03050315. Epub 2015 Nov 13.
6
Arteriovenous Fistula Use in the United States and Dialysis Facility-Level Comorbidity Burden.美国动静脉瘘的使用情况与透析中心的合并症负担。
Am J Kidney Dis. 2020 Jun;75(6):879-886. doi: 10.1053/j.ajkd.2019.08.023. Epub 2019 Nov 22.
7
Associations between published quality ratings of skilled nursing facilities and outcomes of medicare beneficiaries with heart failure.发表的熟练护理设施质量评级与医疗保险心力衰竭受益人的结果之间的关联。
J Am Med Dir Assoc. 2012 Feb;13(2):188.e1-6. doi: 10.1016/j.jamda.2011.04.020. Epub 2011 May 31.
8
Association of Nondisease-Specific Problems with Mortality, Long-Term Care, and Functional Impairment among Older Adults Who Require Skilled Nursing Care after Dialysis Initiation.透析开始后需要专业护理的老年人中,非疾病特异性问题与死亡率、长期护理和功能障碍的关联。
Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2218-2224. doi: 10.2215/CJN.01260216. Epub 2016 Oct 12.
9
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2(Delta)变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络,2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
10
Facility Practice Variation to Help Understand the Effects of Public Policy: Insights from the Dialysis Outcomes and Practice Patterns Study (DOPPS).设施实践差异有助于了解公共政策的影响:来自透析结局和实践模式研究 (DOPPS) 的见解。
Clin J Am Soc Nephrol. 2017 Jan 6;12(1):190-199. doi: 10.2215/CJN.03930416. Epub 2016 Nov 10.

引用本文的文献

1
Predicting SARS-CoV-2 infection among hemodialysis patients using deep neural network methods.利用深度学习方法预测血液透析患者的 SARS-CoV-2 感染。
Sci Rep. 2024 Oct 9;14(1):23588. doi: 10.1038/s41598-024-74967-4.
2
Transportable, portable, wearable and (partially) implantable haemodialysis systems: comparison of technologies and readiness levels.可运输、便携式、可穿戴及(部分)可植入式血液透析系统:技术与技术就绪水平比较
Clin Kidney J. 2024 Aug 24;17(9):sfae259. doi: 10.1093/ckj/sfae259. eCollection 2024 Sep.
3
Comparative analysis of the incidence and mortality of COVID-19 in Korean end-stage kidney disease patients: hemodialysis, peritoneal dialysis, and transplantation.韩国终末期肾病患者中新型冠状病毒肺炎的发病率和死亡率比较分析:血液透析、腹膜透析和肾移植患者情况
Kidney Res Clin Pract. 2025 May;44(3):500-509. doi: 10.23876/j.krcp.23.287. Epub 2024 May 29.
4
SARS-CoV-2 vaccine effectiveness and clinical outcomes in hemodialysis patients: the NHIS-COVID-19 cohort study in South Korea.韩国 NHIS-COVID-19 队列研究:血液透析患者的 SARS-CoV-2 疫苗有效性和临床结局。
Front Public Health. 2024 May 9;12:1372525. doi: 10.3389/fpubh.2024.1372525. eCollection 2024.
5
SARS-CoV-2 Neutralization Capacity in Hemodialysis Patients with and without a Fifth Vaccination with the Updated Comirnaty Original/Omicron BA.4-5 Vaccine.接受和未接受第五剂更新后的科兴原始/奥密克戎BA.4-5疫苗接种的血液透析患者的SARS-CoV-2中和能力
Vaccines (Basel). 2024 Mar 15;12(3):308. doi: 10.3390/vaccines12030308.
6
Closure of Dialysis Clinics in the United States in 2021-2023.2021 - 2023年美国透析诊所的关闭情况
Clin J Am Soc Nephrol. 2024 Jun 1;19(6):778-781. doi: 10.2215/CJN.0000000000000421. Epub 2024 Jan 23.
7
COVID-19 incidence and outcomes among patients with kidney replacement therapy.接受肾脏替代治疗的患者中新冠病毒疾病2019的发病率及治疗结果
Kidney Res Clin Pract. 2023 Sep;42(5):649-659. doi: 10.23876/j.krcp.22.240. Epub 2023 Sep 27.
8
SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves - United States, June 30, 2021-September 27, 2022.SARS-CoV-2 感染率和维持性透析患者死亡率在德尔塔和奥密克戎变异株早期流行期间-美国,2021 年 6 月 30 日-2022 年 9 月 27 日。
MMWR Morb Mortal Wkly Rep. 2023 Aug 11;72(32):871-876. doi: 10.15585/mmwr.mm7232a4.
9
Disasters and kidney care: pitfalls and solutions.灾难与肾脏护理:问题与解决方案。
Nat Rev Nephrol. 2023 Oct;19(10):672-686. doi: 10.1038/s41581-023-00743-8. Epub 2023 Jul 21.
10
Choice of the Dialysis Modality: Practical Considerations.透析方式的选择:实际考量
J Clin Med. 2023 May 7;12(9):3328. doi: 10.3390/jcm12093328.

COVID-19 结局与透析模式和场所的关联。

Associations of COVID-19 Outcomes with Dialysis Modalities and Settings.

机构信息

Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota.

Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, Minnesota.

出版信息

Clin J Am Soc Nephrol. 2022 Oct;17(10):1526-1534. doi: 10.2215/CJN.03400322. Epub 2022 Sep 8.

DOI:10.2215/CJN.03400322
PMID:36400565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9528267/
Abstract

How maintenance dialysis modality, dialysis setting, and residence in a nursing facility have jointly associated with coronavirus disease 2019 (COVID-19)-related outcomes in the United States is relevant to future viral outbreaks. Using Medicare claims, we determined the incidence of COVID-19-related infection, hospitalization, and death between March 15, 2020 and June 5, 2021. The exposure was one of five combinations of dialysis modality and care setting: in-facility hemodialysis without a recent history of skilled nursing facility care, in-facility hemodialysis with a recent history of skilled nursing facility care, hemodialysis in a skilled nursing facility, home hemodialysis, and (home) peritoneal dialysis. Patient-weeks were pooled to estimate the adjusted associations of event incidence with each dialysis modality/setting during four intervals in 2020-2021. Relative to in-facility hemodialysis without a recent history of skilled nursing facility care, home dialysis was associated with 36%-60% lower odds of all events during weeks 12-23 of 2020; 24%-37% lower odds of all events during weeks 24-37 of 2020; 20%-33% lower odds of infection and hospitalization during the winter of 2020-2021; and similar odds of all events thereafter. In contrast, exposure to skilled nursing facilities was associated with 570%-1140% higher odds of all events during spring of 2020, although excess risk attenuated as the pandemic transpired, especially among patients who received hemodialysis in skilled nursing facilities. In conclusion, home dialysis was associated with lower risks of COVID-19 diagnosis, hospitalization, and death until vaccines were available, whereas care in skilled nursing facilities was associated with higher risks.

摘要

在美国,维持透析方式、透析环境和居住在护理机构如何共同与 2019 年冠状病毒病(COVID-19)相关结局相关,这对未来的病毒爆发具有重要意义。利用医疗保险索赔数据,我们确定了 2020 年 3 月 15 日至 2021 年 6 月 5 日期间与 COVID-19 相关的感染、住院和死亡的发生率。暴露因素为透析方式和护理环境的五种组合之一:无近期护理机构护理史的机构内血液透析、有近期护理机构护理史的机构内血液透析、护理机构内血液透析、家庭血液透析和(家庭)腹膜透析。将患者周合并以估计在 2020-2021 年四个时间段内每种透析方式/环境与事件发生率的调整关联。与无近期护理机构护理史的机构内血液透析相比,家庭透析与 2020 年第 12-23 周所有事件的可能性降低 36%-60%;与 2020 年第 24-37 周所有事件的可能性降低 24%-37%;与 2020-2021 年冬季感染和住院的可能性降低 20%-33%;此后发生所有事件的可能性相似。相比之下,在 2020 年春季,暴露于护理机构与所有事件的可能性增加 570%-1140%相关,尽管随着大流行的发展,风险增加逐渐减弱,尤其是在接受护理机构内血液透析的患者中。总之,在疫苗可用之前,家庭透析与 COVID-19 诊断、住院和死亡的风险降低相关,而在护理机构接受护理则与更高的风险相关。